By Carrie Macmillian, Yale Medicine, April 5, 2024 The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to a medicine meant to protect certain immunocompromised people against COVID-19. The medicine, pemivibart (brand name Pemgarda™), is for people …
No increased stroke risk after COVID-19 bivalent vaccine
Batya Swift Yasgur, Medscape, March 28, 2024 Receipt of the bivalent COVID-19 vaccine was not associated with an increased stroke risk in the first 6 weeks after vaccination with either the Pfizer or Moderna vaccines, a new study of Medicare …
COVID-19 variant update
CDC, March 26, 2024 As of March 26, 2024, the SARS-CoV-2 Omicron variant JN.1 has very high prevalence in the United States, with CDC Nowcast projections estimating JN.1 to account for more than 95% of all COVID-19 illnesses in the US. The …
13 things to know about Paxlovid, the latest COVID-19 pill
Kathy Katella, Yale Medicine, March 25, 2024 Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the …
U.S. life expectancy rebounded in 2022 but COVID and drug overdoses were still deadly
Brian Mann, NPR, March 21, 2024 Life expectancy in the U.S. bounced back in 2022 as the COVID-19 pandemic faded, rising from 76.4 years in 2021 to 77.5 years on average. That’s according to two new studies released early Thursday …